ABBVD 債券
以下是 ABBVIE INC CEDEAR EA 10 REP 1 COM(USD) 公司債券的清單。投資者通常選擇公司債券,因為它們在市場波動時具有更高的穩定性。研究價格、收益率和其他統計數據並找到可靠的投資。
商品代碼 | YTM % | 成交量 | 價格 % | 票息 % | 到期日 | 未償金額 | 面值 | 最小面額金額 | 發行人 |
---|---|---|---|---|---|---|---|---|---|
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7.83% | 26 K | 76.04% | 4.75% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7.77% | 16 K | 77.52% | 4.85% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7.67% | 50 K | 77.25% | 4.63% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.95% | 10 K | 86.00% | 4.55% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
6.30% | 6.75 M | 80.27% | 4.25% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.15% | 0 | 84.43% | 4.45% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.07% | 1.78 M | 88.40% | 4.88% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.06% | 96 K | 87.84% | 4.63% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.03% | 284 K | 88.47% | 4.75% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.03% | 6.24 M | 86.18% | 4.40% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.02% | 0 | 88.02% | 4.70% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
6.00% | 234 K | 89.75% | 4.85% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.95% | 10.13 M | 85.20% | 4.05% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.94% | 2.52 M | 94.79% | 5.50% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.89% | 28.69 M | 94.79% | 5.40% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.84% | 1.12 M | 95.60% | 5.35% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.82% | 131 K | 97.58% | 5.60% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.74% | 26 K | 90.47% | 3.20% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.41% | 0 | 92.36% | 4.30% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.32% | 8.78 M | 95.08% | 4.55% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.28% | 0 | 94.93% | 4.50% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.15% | 7.91 M | 100.32% | 5.20% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.08% | 11.07 M | 99.81% | 5.05% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.69% | 6.93 M | 101.20% | 4.95% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.68% | 3.97 M | 94.56% | 3.20% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.54% | 3.03 M | 101.32% | 4.88% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.53% | 0 | 94.35% | 2.63% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
4.45% | 2.38 M | 101.14% | 4.80% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.41% | 4.9 M | 98.01% | 2.95% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.40% | 0 | 98.93% | 3.20% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.37% | 1.82 M | 99.66% | 4.25% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.35% | 1.61 M | 100.75% | 4.65% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.25% | 979 K | 100.91% | 4.80% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
XXS162262122ALLERGAN FNDG 17/29 | 3.94% | 0 | 93.75% | 2.13% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
3.18% | 0 | 89.68% | 1.25% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.90% | 0 | 121.31% | 4.25% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.88% | 0 | 126.76% | 4.75% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.83% | 0 | 128.71% | 4.85% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.77% | 0 | 97.69% | 2.13% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.71% | 0 | 99.72% | 2.63% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.67% | 0 | 98.28% | 2.13% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.52% | 0 | 95.94% | 0.75% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.35% | 0 | 123.74% | 4.55% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
−3.94% | 0 | 111.17% | 2.95% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
— | — | — | 4.40% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |